• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于微小RNA的宫颈病变和癌症指纹图谱分析

MicroRNA-Based Fingerprinting of Cervical Lesions and Cancer.

作者信息

Pisarska Justyna, Baldy-Chudzik Katarzyna

机构信息

Department of Microbiology and Molecular Biology, Collegium Medicum, University of Zielona Gora, 65-561 Zielona Gora, Poland.

出版信息

J Clin Med. 2020 Nov 15;9(11):3668. doi: 10.3390/jcm9113668.

DOI:10.3390/jcm9113668
PMID:33203149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7698009/
Abstract

The regulatory functions of microRNA (miRNA) are involved in all processes contributing to carcinogenesis and response to viral infections. Cervical cancer in most cases is caused by the persistence of high-risk human papillomavirus (HR-HPV) infection. While oncogenic human papillomaviruses induce aberrant expression of many cellular miRNAs, this dysregulation could be harnessed as a marker in early diagnosis of HR-HPV infection, cervical squamous intraepithelial lesions, and cancer. In recent years, growing data indicate that miRNAs show specific patterns at various stages of cervical pathology. The aim of this review is to systematize current reports on miRNA capacity that can be utilized in personalized diagnostics of cervical precancerous and cancerous lesions. The analysis of the resources available in online databases (National Center for Biotechnology Information-NCBI, PubMed, ScienceDirect, Scopus) was performed. To date, no standardized diagnostic algorithm using the miRNA pattern in cervical pathology has been defined. However, the high sensitivity and specificity of the reported assays gives hope for the development of non-invasive diagnostic tests that take into account the heterogeneity of tumor-related changes. Due to this variability resulting in difficult to predict clinical outcomes, precise molecular tools are needed to improve the diagnostic and therapeutic process.

摘要

微小RNA(miRNA)的调控功能参与了所有导致癌症发生和对病毒感染反应的过程。大多数情况下,宫颈癌是由高危型人乳头瘤病毒(HR-HPV)持续感染引起的。虽然致癌性人乳头瘤病毒会诱导许多细胞miRNA的异常表达,但这种失调可作为HR-HPV感染、宫颈鳞状上皮内病变和癌症早期诊断的标志物。近年来,越来越多的数据表明,miRNA在宫颈病理的各个阶段呈现出特定模式。本综述的目的是对目前有关miRNA能力的报告进行系统化整理,这些能力可用于宫颈癌前病变和癌性病变的个性化诊断。我们对在线数据库(美国国立生物技术信息中心-NCBI、PubMed、ScienceDirect、Scopus)中的可用资源进行了分析。迄今为止,尚未定义在宫颈病理中使用miRNA模式的标准化诊断算法。然而,所报道检测方法的高灵敏度和特异性为开发考虑肿瘤相关变化异质性的非侵入性诊断测试带来了希望。由于这种变异性导致难以预测临床结果,因此需要精确的分子工具来改善诊断和治疗过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/7698009/523665769faf/jcm-09-03668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/7698009/523665769faf/jcm-09-03668-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/7698009/523665769faf/jcm-09-03668-g001.jpg

相似文献

1
MicroRNA-Based Fingerprinting of Cervical Lesions and Cancer.基于微小RNA的宫颈病变和癌症指纹图谱分析
J Clin Med. 2020 Nov 15;9(11):3668. doi: 10.3390/jcm9113668.
2
Role of microRNAs as biomarkers of cervical carcinogenesis: a systematic review.微小RNA作为宫颈癌发生生物标志物的作用:一项系统综述。
Obstet Gynecol Sci. 2021 Sep;64(5):419-436. doi: 10.5468/ogs.21123. Epub 2021 Aug 13.
3
4
The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas.三种最常见的人乳头瘤病毒致癌类型及其在泰国宫颈癌前病变和癌症妇女中的整合状态。
J Med Virol. 2014 Nov;86(11):1911-9. doi: 10.1002/jmv.24034. Epub 2014 Aug 5.
5
MicroRNAs as markers of progression in cervical cancer: a systematic review.微小 RNA 作为宫颈癌进展的标志物:系统评价。
BMC Cancer. 2018 Jun 27;18(1):696. doi: 10.1186/s12885-018-4590-4.
6
Cervical Cancer, Papillomavirus, and miRNA Dysfunction.宫颈癌、乳头瘤病毒与微小RNA功能障碍
Front Mol Biosci. 2021 Dec 10;8:758337. doi: 10.3389/fmolb.2021.758337. eCollection 2021.
7
The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.miR-409-3p 在调控人宫颈高级别鳞状上皮内病变中 HPV16/18-E6mRNA 中的作用。
Antiviral Res. 2019 Mar;163:185-192. doi: 10.1016/j.antiviral.2019.01.019. Epub 2019 Jan 31.
8
From squamous intraepithelial lesions to cervical cancer: Circulating microRNAs as potential biomarkers in cervical carcinogenesis.从鳞状上皮内病变到宫颈癌:循环 microRNAs 作为宫颈癌发生的潜在生物标志物。
Biochim Biophys Acta Rev Cancer. 2019 Dec;1872(2):188306. doi: 10.1016/j.bbcan.2019.08.001. Epub 2019 Aug 6.
9
A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer.miRNAs 失调与宫颈癌相关的全面综述
Curr Genomics. 2014 Aug;15(4):310-23. doi: 10.2174/1389202915666140528003249.
10
Genome-wide discovery of viral microRNAs based on phylogenetic analysis and structural evolution of various human papillomavirus subtypes.基于系统发育分析和各种人乳头瘤病毒亚型的结构进化,对病毒 microRNA 进行全基因组发现。
Brief Bioinform. 2018 Nov 27;19(6):1102-1114. doi: 10.1093/bib/bbx046.

引用本文的文献

1
Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus.用于测量血清和宫颈黏液中 microRNA 和细胞因子的宫颈癌辅助检测试验的性能。
Cancer Sci. 2024 Aug;115(8):2795-2807. doi: 10.1111/cas.16214. Epub 2024 May 15.
2
Molecular aspects of cervical cancer: a pathogenesis update.宫颈癌的分子学研究进展:发病机制的最新情况
Front Oncol. 2024 Mar 19;14:1356581. doi: 10.3389/fonc.2024.1356581. eCollection 2024.
3
Hsa-miR-194-5p and hsa-miR-195-5p are down-regulated expressed in high dysplasia HPV-positive Pap smear samples compared to normal cytology HPV-positive Pap smear samples.

本文引用的文献

1
HPV-CCDC106 integration alters local chromosome architecture and hijacks an enhancer by three-dimensional genome structure remodeling in cervical cancer.HPV-CCDC106 整合通过宫颈癌的三维基因组结构重塑改变局部染色体结构并劫持增强子。
J Genet Genomics. 2020 Aug;47(8):437-450. doi: 10.1016/j.jgg.2020.05.006. Epub 2020 Jun 11.
2
Identification of Prognostic miRNA Signature and Lymph Node Metastasis-Related Key Genes in Cervical Cancer.宫颈癌中预后性miRNA特征及淋巴结转移相关关键基因的鉴定
Front Pharmacol. 2020 May 8;11:544. doi: 10.3389/fphar.2020.00544. eCollection 2020.
3
MicroRNA Involvement in Signaling Pathways During Viral Infection.
与正常细胞学 HPV 阳性巴氏涂片样本相比,高不典型增生 HPV 阳性巴氏涂片样本中 hsa-miR-194-5p 和 hsa-miR-195-5p 的表达下调。
BMC Infect Dis. 2024 Feb 12;24(1):182. doi: 10.1186/s12879-023-08942-1.
4
CESCProg: a compact prognostic model and nomogram for cervical cancer based on miRNA biomarkers.CESCProg:基于 miRNA 生物标志物的宫颈癌紧凑预后模型和诺莫图。
PeerJ. 2023 Sep 27;11:e15912. doi: 10.7717/peerj.15912. eCollection 2023.
5
Nomogram for predicted probability of cervical cancer and its precursor lesions using miRNA in cervical mucus, HPV genotype and age.基于宫颈黏液中的 miRNA、HPV 基因型和年龄预测宫颈癌及其前病变概率的列线图。
Sci Rep. 2022 Sep 28;12(1):16231. doi: 10.1038/s41598-022-19722-3.
6
Role of immunocytochemistry in cervical cancer screening.免疫细胞化学在宫颈癌筛查中的作用。
Cytojournal. 2022 Jun 14;19:42. doi: 10.25259/CMAS_03_17_2022. eCollection 2022.
7
Identification of Two Exosomal miRNAs in Circulating Blood of Cancer Patients by Using Integrative Transcriptome and Network Analysis.通过整合转录组和网络分析鉴定癌症患者循环血液中的两种外泌体微小RNA
Noncoding RNA. 2022 May 12;8(3):33. doi: 10.3390/ncrna8030033.
8
The Autophagy Process in Cervical Carcinogenesis: Role of Non-Coding-RNAs, Molecular Mechanisms, and Therapeutic Targets.非编码 RNA 在宫颈癌发生中的自噬作用:分子机制及治疗靶点
Cells. 2022 Apr 13;11(8):1323. doi: 10.3390/cells11081323.
9
miR-146b-5p promotes colorectal cancer progression by targeting TRAF6.微小RNA-146b-5p通过靶向肿瘤坏死因子受体相关因子6促进结直肠癌进展。
Exp Ther Med. 2022 Mar;23(3):231. doi: 10.3892/etm.2022.11155. Epub 2022 Jan 20.
10
New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers.妇科癌前病变和早期癌症检测的新趋势
Cancers (Basel). 2021 Dec 17;13(24):6339. doi: 10.3390/cancers13246339.
病毒感染期间微小RNA参与信号通路
Front Cell Dev Biol. 2020 Mar 10;8:143. doi: 10.3389/fcell.2020.00143. eCollection 2020.
4
microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6.microRNA-499a 通过靶向 SOX6 促进宫颈癌细胞的进展和化疗耐药性。
Apoptosis. 2020 Apr;25(3-4):205-216. doi: 10.1007/s10495-019-01588-y.
5
Differences in Stability of Viral and Viral-Cellular Fusion Transcripts in HPV-Induced Cervical Cancers.HPV 诱导的宫颈癌中病毒和病毒-细胞融合转录本稳定性的差异。
Int J Mol Sci. 2019 Dec 23;21(1):112. doi: 10.3390/ijms21010112.
6
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.2018 年归因于感染的癌症全球负担:全球发病率分析。
Lancet Glob Health. 2020 Feb;8(2):e180-e190. doi: 10.1016/S2214-109X(19)30488-7. Epub 2019 Dec 17.
7
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.2018 年宫颈癌发病率和死亡率的估计:全球分析。
Lancet Glob Health. 2020 Feb;8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6. Epub 2019 Dec 4.
8
A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis.一组 microRNAs 协同控制肿瘤发生、侵袭和转移。
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24184-24195. doi: 10.1073/pnas.1913307116. Epub 2019 Nov 8.
9
Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer.人乳头瘤病毒16/18-E6/E7对miR-375/AEG-1轴的失调促进宫颈癌的细胞增殖、迁移和侵袭。
Front Oncol. 2019 Sep 9;9:847. doi: 10.3389/fonc.2019.00847. eCollection 2019.
10
Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types.多癌种中 APOBEC 突变特征、APOBEC3 基因表达和种系缺失的综合基因组分析,以及免疫原性。
BMC Med Genomics. 2019 Sep 18;12(1):131. doi: 10.1186/s12920-019-0579-3.